Free Trial
→ Three new patents reveal Elon and Trump’s secret “Project America” (From Timothy Sykes) (Ad) Free LENZ Stock Alerts

LENZ Therapeutics (LENZ) SEC Filings & 10K Form

LENZ Therapeutics logo
$21.54 -0.29 (-1.33%)
Closing price 03/3/2025 04:00 PM Eastern
Extended Trading
$21.56 +0.03 (+0.12%)
As of 03/3/2025 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent LENZ Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
01/13/2025
4:26 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:20 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:22 PM		Chevallard Daniel R. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:24 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Odrich Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
6:55 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
4:08 PM		LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SC 13D/A
11/06/2024
7:03 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
11/06/2024
7:06 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
11/06/2024
6:35 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:26 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
7:23 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
10/28/2024
7:24 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
10/28/2024
7:09 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
11:15 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form EFFECT
09/19/2024
4:04 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
09/11/2024
3:09 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/14/2024
3:25 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
08/12/2024
7:05 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:11 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
07/29/2024
3:12 PM		LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Ridgeback Capital Investments L.P. (Filed by)
Form SC 13G
07/23/2024
7:16 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
7:32 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
07/15/2024
7:22 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
7:31 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/14/2024
4:29 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
MCCOLLUM JAMES W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:18 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
05/08/2024
4:11 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/10/2024
6:37 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
04/10/2024
11:15 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form EFFECT
04/08/2024
1:46 PM		EcoR1 Capital, LLC (Filed by)
LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Form SC 13G/A
04/03/2024
6:32 AM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
3:46 PM		LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/28/2024
3:31 PM		Alpha Wave Global, LP (Reporting)
Alpha Wave Ventures GP, Ltd (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/28/2024
3:30 PM		Alpha Wave Ventures GP, Ltd (Filed by)
LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Form SC 13G
03/25/2024
7:32 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
7:33 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Odrich Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
7:34 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
7:36 PM		Chevallard Daniel R. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
7:38 PM		George Jeffrey P. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
7:38 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Scheiner Zachary (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2024
7:39 PM		Drapkin Kimberlee C (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)

If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.

You MUST act before March 17th.
03/25/2024
7:40 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Scheiner Zachary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
7:40 PM		Guerard Frederic (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
7:42 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
MCCOLLUM JAMES W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
7:42 PM		LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
Form SC 13G/A
03/25/2024
7:44 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
7:44 PM		Kolchinsky Peter (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2024
7:48 PM		Kolchinsky Peter (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
7:10 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2024
7:14 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Odrich Marc (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2024
7:18 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2024
7:20 PM		Chevallard Daniel R. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2024
7:22 PM		George Jeffrey P. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2024
7:24 PM		Guerard Frederic (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2024
7:26 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
MCCOLLUM JAMES W (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2024
7:28 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Thunen Shelley B (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2024
3:19 PM		LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Versant Venture Capital VII, L.P. (Reporting)
Versant Ventures VII GP, L.P. (Reporting)
Versant Ventures VII GP-GP, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2024
3:31 PM		Graphite Bio, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
3:37 PM		Graphite Bio, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2024
4:17 PM		Graphite Bio, Inc. (Subject)
LENZ Therapeutics (Subject)
Form 425
03/08/2024
4:13 PM		Graphite Bio, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
5:08 AM		Graphite Bio, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
5:09 AM		Graphite Bio, Inc. (Subject)
LENZ Therapeutics (Subject)
Form 425
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:LENZ) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...
Crypto Swap Profits | Sponsored
Leaked Trump video exposes his secret stocks
Ten investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...
Porter & Company | Sponsored
Texas approves new currency
Rural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...
Stansberry Research | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...
Investors Alley | Sponsored
DOGE Social Security bombshell?
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored
Trump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out
This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...
American Alternative | Sponsored
This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored